Mitchell Pease’s Post

As Patrick mentions, if you're heading to Chicago for American Academy of Ophthalmology and work in precision medicine, this event is for you! If you have interest or any questions please feel free to reach out to any of the Sano team or send a message to events@sanogenetics.com, as this is an invite only event! #conference #ophthalmology #precisionmedicine

Great blog from Sano Genetics if you're interested in the role of genetics in CKD and the potential of precision medicine!

🌍 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟭𝟬𝘁𝗵 𝗶𝘀 𝗪𝗼𝗿𝗹𝗱 𝗠𝗲𝗻𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗗𝗮𝘆 🌍 What does mental health mean to you? For many, it’s about finding balance, building resilience, and prioritizing self-care. Yet, it’s also about recognising that mental health challenges affect millions globally. 🔹 𝟭 𝗶𝗻 𝟴 𝗽𝗲𝗼𝗽𝗹𝗲 worldwide live with a mental health condition. 🔹 Anxiety and depression are leading causes of disability, yet 𝟳𝟱% of people in low-income countries don’t receive the care they need. 🔹 In the workplace, mental health issues can reduce productivity by up to 𝟯𝟱%. Today is a reminder that mental health matters just as much as physical health. Whether it’s checking in on a colleague, offering support, or simply taking a moment for yourself—small steps make a big difference. Let’s break the stigma and create environments where everyone feels supported. 💬💚 #WorldMentalHealthDay #MentalHealthMatters #BreakTheStigma #MentalHealthAwareness

🎉 Congratulations to Victor Ambros and Gary Ruvkun, the 2024 Nobel Prize winners in Physiology or Medicine! 🧬 Their groundbreaking discovery of microRNAs and their role in regulating gene expression has transformed our understanding of how cells develop and function. This vital discovery, first made in C. elegans, has opened new doors in gene regulation research and is essential for understanding diseases like cancer and diabetes. #NobelPrize #GeneRegulation #microRNA #Biotech

🔄 𝗣𝗮𝗿𝗮𝗱𝗶𝗴𝗺 𝗦𝗵𝗶𝗳𝘁 𝗶𝗻 𝗣𝗮𝘁𝗶𝗲𝗻𝘁-𝗟𝗲𝗱 𝗧𝗿𝗶𝗮𝗹𝘀: 𝗙𝗿𝗼𝗺 "𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮𝘀 𝗣𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁𝘀" 𝘁𝗼 "𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮𝘀 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀" A topic we are all familiar with, and one that has been at the forefront of clinical studies for years, is still undergoing a fundamental transformation. Patients are evolving from passive participants to active partners in the research process. No longer just data sources, they are now co-creators, shaping trial design, outcomes, and decision-making. This shift empowers patients with real-world insights, leading to more patient-centered solutions and improved outcomes. It’s not just about involvement—it’s about true collaboration. But are we as an industry doing enough to support this shift? #PatientCentric #ClinicalTrials #PatientEngagement #InnovationInHealthcare

Last week, I heard Andy Lee discuss targeting a specific gene in a lung cancer trial, describing the eligible patient population as akin to "finding a needle in a haystack." When genetic drivers or variants are included in a study's inclusion/exclusion (I/E) criteria, finding eligible patients becomes incredibly challenging, time-consuming, and expensive. It made me reflect on how Sano Genetics is adding value, especially given our at-home genetic testing and focus on precision medicines. These complexities in precision medicine are exactly why Sano Genetics was founded: to streamline the patient experience for both sponsors and participants, increasing education, awareness, and accessibility. As an industry, I believe that through collaborations and partnerships, we can remove these barriers and burdens, bringing life-changing medicines to market. #genetics #biomarkers #clinicalstudies

As many of you know, I attended two conferences last week: DPharm and Mobile Tech in Clinical Trials. Reflecting on the key topics, one quote that particularly stood out to me was from a talk with Eileen Babcock (AstraZeneca) and Joe O'Rourke (Walgreens Clinical Trials). "𝗪𝗲 𝗻𝗲𝗲𝗱 𝘁𝗼 𝗺𝗮𝗸𝗲 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗲𝗮𝘀𝗶𝗲𝗿 𝘁𝗼 𝗳𝗶𝗻𝗱, 𝗲𝗮𝘀𝗶𝗲𝗿 𝘁𝗼 𝗲𝗻𝗿𝗼𝗹 𝗮𝗻𝗱 𝗽𝗮𝘁𝗶𝗲𝗻𝘁-𝗳𝗿𝗶𝗲𝗻𝗱𝗹𝘆". While this may sound like common sense—and has been a focus for the past few years—we still have a long way to go to improve education and accessibility in clinical trials. Being part of Sano Genetics has opened my eyes to what’s possible in empowering patients allowing seamless and smooth trial access. Though I imagine this topic will continue to be a focus for years to come, it’s inspiring to see efforts being made not only at Sano but across the industry to shift the mindset from viewing "𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮𝘀 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁𝘀" to "𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗮𝘀 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀" in trials. I’m excited to see the advancements in this space and to continue working with Sano to help accelerate this progress! #conference #clinicaltrials #patientempowerment

𝙒𝙚𝙡𝙡, 𝙩𝙝𝙖𝙩’𝙨 𝙖 𝙬𝙧𝙖𝙥 𝙤𝙣 DPHARM: Disruptive Innovations to Modernize Clinical Research 𝙖𝙣𝙙 𝙈𝙤𝙗𝙞𝙡𝙚 𝙏𝙚𝙘𝙝 𝙞𝙣 𝘾𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙏𝙧𝙞𝙖𝙡𝙨! It has been an incredibly informative few days with some key takeaways about the future of clinical research (stay tuned for more posts on this!). It has also been a pleasure to enjoy the experience alongside, Hadley Sheppard, PhD, Julian Moxon, and Patrick Short! As I recover from my travels (1 plane, 2 trains, 2 Ubers and 10 hours later!), I want to thank everyone I met during the conference. It was great reconnecting with old contacts and making new ones! Special shoutout to you, Sabina Kineen! I’m excited to continue many of the discussions from the past few days, particularly around increasing accessibility and awareness in clinical trials. #conference #DPharm2024 #philadelphia #MobileTechinClinicalTrials2024